AI-Based Discovery of Biomarkers and Therapeutic Targets in Human Cancers

Despite emerging new therapies, cancer remains the second leading cause of death in the United States. Clinical tools to select optimal treatment options suitable for individual cancer patients are currently lacking. 

To meet these market needs, this project will employ an established cutting-edge artificial intelligence (AI)/big data technology to determine the best treatments for individual patients and identify novel therapeutic targets to improve cancer outcomes.